New fraternine analogues: Evaluation of the antiparkinsonian effect in the model of Parkinson's disease-Reference-Cited by-同舟云学术

New fraternine analogues: Evaluation of the antiparkinsonian effect in the model of Parkinson's disease

Published:2024-02 Issue: Volume:103 Page:102390
ISSN:0143-4179
Container-title:Neuropeptides
language:en
Short-container-title:Neuropeptides

Author:

Mayer Andréia Biolchi,Amaral Henrique de Oliveira,de Oliveira Danilo Gustavo R.,Campos Gabriel Avohay Alves,Ribeiro Priscilla Galante,Fernandes Solange Cristina Rego,de Souza Adolfo Carlos Barros,de Castro Raffael Júnio Araújo,Bocca Anamélia Lorenzetti,Mortari Márcia Renata

Funder

Fundação de Apoio à Pesquisa do Distrito Federal

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Neurology,Endocrinology,General Medicine

Reference57 articles.

1. Neuropsychiatric symptoms in Parkinson’s disease;Aarsland;Mov. Disord.,2009

2. The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson’s disease: mechanisms of action;Athauda;Drug Discov. Today,2016

3. Exenatide once weekly versus placebo in Parkinson’s disease: a randomised, double-blind, placebo-controlled trial;Athauda;Lancet,2017

4. Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson’s disease;Aviles-Olmos;J. Parkinsons Dis.,2015

5. Bee venom for the treatment of Parkinson’s disease: how far is it possible?;Awad;Biomed. Pharmacother.,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bee venom as a promising therapeutic strategy in central nervous system diseases;Neuropeptides;2024-10